1-2 of 2
cost of illness
Close
Sort by
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 234–239.
https://doi.org/10.1182/asheducation-2014.1.234
Published: 2014